Jerome Wojcik, CEO of Quartz Bio will discuss the topic of Reproducible Research within the course of Changing Paradigms in Clinical Development held by the Swiss Biotech Association Academy, on the 27 May 2015 (Bern, Switzerland)
This topic will be at the center of the ELIXIR Innovation and SME Forum that will take place Tuesday 9th of June during the BC2 conference in Basel, Switzerland. Jerome Wojcik, CEO of Quartz Bio will discuss the Data challenges and opportunities from an SME perspective.
The PRECISESADS project aims at using the power of OMICs, and bioinformatics to identify new classifications for systemic autoimmune diseases (SADs). The project is featured in the article: Towards the taxonomy of human diseases in the January issue of Nature Reviews Drug Discovery.
Quartz Bio is leading the Data Analysis, Bioinformatics and biostatistics work-package of PRECISESADS.
Cape Town based CPGR (Centre for Proteomic & Genomic Research) and Geneva-based Quartz Bio S.A. form partnership to provide integrated biomarker solutions to pharmaceutical industry.